Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dupixent
Dupixent
Trials to watch: Four biologics concluding pivotal COPD trials
Clinical Trials Arena
Thu, 07/25/24 - 11:36 am
COPD
biologics
clinical trials
GSK
Nucala
AstraZeneca
Fasenra
Roche
astegolimab
Sanofi
Regeneron
Dupixent
Sanofi lifts 2024 profit forecast on strength in Dupixent, new products
Reuters
Thu, 07/25/24 - 11:26 am
Sanofi
Dupixent
earnings
Sanofi and Regeneron's Dupixent scores in Europe as the first biologic to treat COPD
Fierce Pharma
Wed, 07/3/24 - 11:26 am
Sanofi
Regeneron
Europe
COPD
Dupixent
Sanofi reports positive data from Phase III EoE treatment trial
Clinical Trials Arena
Thu, 06/27/24 - 11:29 am
Sanofi
Dupixent
eosinophilic esophagitis
clinical trials
Dupixent repeats as top pharma ad brand, rankings largely unchanged in May
Medical Marketing and Media
Tue, 06/11/24 - 10:49 pm
pharma advertising
DTC advertising
Dupixent
Regeneron
Sanofi
Dupixent nears EU approval for COPD, as FDA delays
Pharmaphorum
Fri, 05/31/24 - 10:49 am
Sanofi
Regeneron
Dupixent
COPD
EMA
Europe
FDA
Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD
Fierce Pharma
Mon, 05/20/24 - 11:25 am
Amgen
AstraZeneca
COPD
Sanofi
Regeneron
Tezspire
Dupixent
Dupixent recaptures top Rx, OTC pharma brand spot in April
Medical Marketing and Media
Wed, 05/8/24 - 11:03 pm
DTC advertising
Dupixent
Sanofi
Regeneron
Dupixent’s DU More campaign breathes life into asthma treatment space
Medical Marketing and Media
Mon, 04/29/24 - 09:53 am
Dupixent
DTC advertising
Sanofi
Regeneron
AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again
Fierce Pharma
Fri, 04/26/24 - 11:18 am
AbbVie
Rinvoq
Regeneron
Sanofi
Dupixent
atopic dermatitis
COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024
BioSpace
Wed, 03/27/24 - 11:06 am
COPD
Sanofi
Regeneron
Verona Pharma
Dupixent
ensifentrine
After decades of waiting, late-stage therapies may penetrate the COPD market this year
Clinical Trials Arena
Sun, 03/24/24 - 10:31 pm
COPD
drug development
Sanofi
Regeneron
Dupixent
Verona
ensifentrine
Incyte, itching for a piece of Dupixent's market, hits goals in midphase skin disease trial
Fierce Biotech
Mon, 03/11/24 - 11:52 am
Incyte
clinical trials
prurigo nodularis
povorcitinib
Dupixent
Sanofi
Regeneron
Takeda’s Eohilia to compete Sanofi’s Dupixent in eosinophilic esophagitis treatment
Clinical Trials Arena
Thu, 02/29/24 - 11:11 am
Takeda
Eohilia
Sanofi
Dupixent
EoE
eosinophilic esophagitis
Sanofi, Regeneron Secure FDA Priority Review for Dupixent in COPD
BioSpace
Fri, 02/23/24 - 10:43 am
FDA
Sanofi
Regeneron
Dupixent
priority review
COPD
Could Dupixent find a new life targeting ‘memory’ B cells to treat allergies?
Fierce Biotech
Fri, 02/9/24 - 11:20 am
allergies
Dupixent
Sanofi
Sanofi Q4 earnings hit by weak dollar, generic competition
Reuters
Thu, 02/1/24 - 11:25 am
Sanofi
earnings
Dupixent
Aubagio
Sanofi, Regeneron Win Dupixent Label Expansion to Treat Eosinophilic Esophagitis
BioSpace
Fri, 01/26/24 - 11:19 am
Regeneron
Sanofi
Dupixent
eosinic esophagitis
pediatric
FDA
FDA updates Sanofi’s Dupixent label for atopic dermatitis
Pharmaceutical Business Review
Wed, 01/17/24 - 09:26 am
Sanofi
Dupixent
FDA
atopic dermatitis
Dupixent for cancer? Researchers test blockbuster med as an immunotherapy-booster
Fierce Biotech
Thu, 12/7/23 - 11:13 pm
Regeneron
Sanofi
Dupixent
cancer
lung cancer
Pages
1
2
3
4
5
6
7
8
next ›
last »